Breakthroughs in the treatment of chronic obstructive pulmonary disease (COPD) appear to be on the horizon in thoracic medicine. Surya P. Bhatt, MD, MSPH, contextualized the encouraging results from multiple clinical trials discussed at the ATS 2024 International Conference.

Recent developments in bronchiectasis discussed at ATS 2024 reflect the growing interest and continued progression in advancing research and patient care for people with the disease. George M. Solomon, MD, shared his perspective on these continued efforts and why there’s reason for optimism moving forward.

The latest advancements in the understanding of the epidemiology, pathophysiology, and therapies for bronchiectasis will be highlighted in the ATS 2024 International Conference scientific program. Nirupama Putcha, MD, MHS, previews the hot topics of discussion among bronchiectasis specialists.

New insights into the diagnosis, management, and prevention of COPD will be highlighted in the ATS 2024 International Conference scientific program. Nirupama Putcha, MD, MHS, discussed the important dialogues among COPD specialists and what these respiratory health professionals can expect from ATS 2024 San Diego this May.

The ATS 2024 International Conference offers a robust scientific program featuring several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in bronchiectasis and COPD.